Literature DB >> 2882771

Beta-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect.

S B Bittiner, S E Smith.   

Abstract

The influence of vagal and sympathetic efferent activity on sinus arrhythmia in man has been studied in six healthy subjects by administration of hyoscine butylbromide and/or various beta-adrenoceptor blocking drugs using a microcomputer-linked electrocardiogram system. Sinus arrhythmia was quantitated as the s.d. of the R-R interval. Sinus arrhythmia was almost abolished by hyoscine butylbromide irrespective of the absence or presence and nature of the beta-adrenoceptor blocking drug. Atenolol and metoprolol alone prolonged the mean R-R interval and increased sinus arrhythmia. Oxprenolol, a drug with modest partial agonist or intrinsic sympathomimetic activity (ISA), prolonged the mean R-R interval to a lesser extent but had no effect on sinus arrhythmia. Xamoterol, which has high ISA, shortened the mean R-R interval but had no effect on sinus arrhythmia. These data yielded a non-linear relationship between sinus arrhythmia and mean R-R interval. Exaggerated sinus arrhythmia appears to accompany beta-adrenoceptor blockade only in the absence of ISA when bradycardia ensues. These findings are consistent with the hypothesis that the exaggeration in sinus arrhythmia is due to a central vagotonic effect secondary to the action of the drugs in the periphery. Changes in R-R interval induced by the adrenoceptor blocking drugs were altered to some extent by vagal blockade. This observation is consistent with the hypothesis that changes in heart rate induced by such drugs are determined in part by a change in vagal tone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2882771      PMCID: PMC1401218          DOI: 10.1111/j.1365-2125.1986.tb02959.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Discharges in mammalian sympathetic nerves.

Authors:  E D Adrian; D W Bronk; G Phillips
Journal:  J Physiol       Date:  1932-02-08       Impact factor: 5.182

2.  The antagonistic cardiac nerves and heart rate.

Authors:  A Samaan
Journal:  J Physiol       Date:  1935-02-09       Impact factor: 5.182

3.  The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.

Authors:  T Hashimoto; A Shiina; T Toyo-Oka; S Hosoda; K Kondo
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

4.  Reflex discharge patterns of cardiac vagal efferent fibres.

Authors:  D L Kunze
Journal:  J Physiol       Date:  1972-04       Impact factor: 5.182

5.  The in vitro pharmacology of xamoterol (ICI 118,587).

Authors:  E Malta; M A Mian; C Raper
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

6.  Cardiac denervation in diabetes.

Authors:  T Wheeler; P J Watkins
Journal:  Br Med J       Date:  1973-12-08

7.  The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.

Authors:  A Nuttall; H M Snow
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

8.  Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade.

Authors:  R Coker; A Koziell; C Oliver; S E Smith
Journal:  J Physiol       Date:  1984-11       Impact factor: 5.182

9.  Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control.

Authors:  P G Katona; F Jih
Journal:  J Appl Physiol       Date:  1975-11       Impact factor: 3.531

10.  The effect of atenolol on the spontaneous and reflex activity of the sympathetic nerves in the cat: influence of cardiopulmonary receptors.

Authors:  E M Scott
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

View more
  6 in total

Review 1.  Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  R Furlong; R N Brogden
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

2.  Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability.

Authors:  Mara Mather; Hyun Joo Yoo; David V Clewett; Tae-Ho Lee; Steven G Greening; Allison Ponzio; Jungwon Min; Julian F Thayer
Journal:  Neuroimage       Date:  2017-02-17       Impact factor: 6.556

Review 3.  Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans.

Authors:  Jani Penttilä; Tom Kuusela; Harry Scheinin
Journal:  Eur J Clin Pharmacol       Date:  2005-08-30       Impact factor: 2.953

4.  Dynamic behavior of the locus coeruleus during arousal-related memory processing in a multi-modal 7T fMRI paradigm.

Authors:  Heidi Il Jacobs; Nikos Priovoulos; Benedikt A Poser; Linda Hg Pagen; Dimo Ivanov; Frans Rj Verhey; Kâmil Uludağ
Journal:  Elife       Date:  2020-06-24       Impact factor: 8.140

5.  Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction.

Authors:  M de Marneffe; P Waterschoot; A Bernard; P Dubois; F Boujelben; I Liebens; M Englert
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

Review 6.  The physiological basis and measurement of heart rate variability in humans.

Authors:  Adina E Draghici; J Andrew Taylor
Journal:  J Physiol Anthropol       Date:  2016-09-28       Impact factor: 2.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.